SUBSTITUTED THIAZOLE LINKED MURRAYANINE-SCHIFF’S BASE DERIVATIVES AS POTENTIAL ANTI-BREAST CANCER CANDIDATES: FUTURE EGFR KINASE INHIBITORS
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2017, Vol 9, Issue 3
Abstract
Cancer is the second leading causes of mortality across the planet which has had affected millions. In spite of massive efforts in producing new molecules and chemotherapeutic approaches for managing cancer, it continued to be the global threat. Small hybrid molecules have gained popularity in chemotherapy due to their potential and smart characteristics in modulating biological targets. The present research attempts in developing few novel hybridized derivatives of murrayanine (an active carbazole derivative) by the semi-synthetic approach to form substituted thiazole linked murrayanine-Schiff’s base derivatives. The protocol involved murrayanine 1 as the template material for constructing a hybridized Schiff’s base intermediate 3, which further by Hantzch’s cyclization was subsequently converted to various hybridized thiazoles analogs 5a-5f. The purity of the synthesized compounds was ascertained by sophisticated analytical techniques. The anti-cancer potential was screened against breast cancer cell lines; MCF-7 and MDA-MB-231 by Sulforhodamine B (SRB) assay. The compound 5b displayed most potent anti-proliferative activity with IC50 values of 23.41μM against MCF-7 cell line and 32.15μM against MDA-MB-231 cell line. It has been observed that analogs having electron withdrawing substituents exhibited pronounced anticancer activity. The docking study was performed by Autodock Vina where the results were found to be in full agreement with the cytotoxic study, depicting that the probable cytotoxic outcome by EGFR inhibitory mechanism. The study revealed the potential of novel hybridized derivatives as active anti-breast cancer candidates. The research will encourage (medicinal) chemists in rationally designing of semi-synthetic analogs of a heterocyclic prototype having pronounced anti-cancer activity.
Authors and Affiliations
Debarshi Kar Mahapatra, Devashish Das, Ruchi Shivhare
Keywords
Related Articles
- EP ID EP617876
- DOI 10.25004/IJPSDR.2017.090307
- Views 85
- Downloads 0
DETERMINATION OF MICROBIAL LOAD IN MULTIVITAMIN AND COUGH SYRUPS SOLD IN DHAKA CITY
The production of substandard drugs and use of inappropriate methods in manufacturing medical products in pharmaceutical industries may cause non-therapeutic effect in patients particularly in children. Hence this study...
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MICROSPHERES OF ATORVASTATIN USING CHITOSAN AND ALGINATE
Certain problems regarding the drugs like high first pass metabolism, also the bioavailability of the certain drugs varies due to instability in acidic environment of stomach. Hence, to resolve such problems the drug sho...
ESTIMATION OF ELETRIPTAN HYDROBROMIDE IN ORAL FILM DOSAGE FORM BY RP-HPLC
A simple, precise, rapid and accurate RP-HPLC method was developed for the percentage drug release estimation of Eletriptan Hydrobromide in oral film dosage form. Eletriptan Hydrobromide is used to treat severe migraine...
ANTI-INFLAMMATORY ACTIVITY AND TOTAL FLAVONOID CONTENT OF AEGLE MARMELOS SEEDS
The anti-inflammatory effect of aqueous and methanol extracts of Aegle marmelos seeds was evaluated using carrageenan induced paw edema and cotton pellets induced granuloma in rats. To prove the dependency of pharmacolog...
CARDIOPROTECTIVE ACTIVITY OF ETHANOLIC EXTRACT OF CITRUS GRANDIS (L.) OSBECK PEEL ON DOXORUBICIN AND CYCLOPHOSPHAMIDE INDUCED CARDIOTOXICITY IN ALBINO RATS
The present study was designed to evaluate the cardioprotective potential of Citrus grandis (L.) Osbeck (CGO) peel extract in rats. Citrus grandis (L.) Osbeck peel extract was evaluated for protection against cyclophosph...